Pitt Street Research reports Anteo Diagnostics is making steady progress in commercialising what is arguably the world’s most versatile surface modification technology.
Pitt Street Research has amended its modeling for Anatara Lifesciences, believing the loss of partner Zoetis is only a temporary set-back.
Peter Switzer of the Switzer Super Report ponders whether BHP has run as far as it could go.
Peter Switzer of the Switzer Super Report lists 24 stocks that had a weak first half of 2019 that could come good in the second.
With tern deposit rates now negligible, Peter Switzer of the Switzer Super Report discusses yield stocks as an alternative.
Pitt Street Research interviewed MyFiziq CEO Vlado Bosanac
Pitt Street Research has initiated coverage of Sensera, technology company expected to piggyback on new applications in medical and industrial sectors, as well as the Internet of Things.
Peter Switzer of the Switzer Super Report has suggestions as to how to position for the US-China trade war.
Peter Switzer of the Switzer Super Report ticks off the boxes of recent developments that are positive for Australian stocks.
Marc Kennis of Pitt Street Research recently sat down with Ralph Schmitt, CEO of Sensera.